Cormorant Asset Management
$2.0B 13F equity value
59 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Cormorant Asset Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 640,000 | $214M | 11.0% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $136M | 7.0% |
| PBLS | PARABILIS MEDICINES INC | 4,615,612 | $126M | 6.5% |
| RAPP | RAPPORT THERAPEUTICS INC | 2,657,521 | $111M | 5.7% |
| ERAS | ERASCA INC | 6,000,000 | $110M | 5.6% |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,510,000 | $102M | 5.2% |
| EYPT | EYEPOINT INC | 7,000,000 | $100M | 5.1% |
| ALMS | ALUMIS INC | 3,285,596 | $92M | 4.7% |
| ABVX | ABIVAX SA | 675,000 | $90M | 4.6% |
| DNTH | DIANTHUS THERAPEUTICS INC | 750,000 | $73M | 3.7% |
Track Cormorant Asset Management's 13F portfolio: $2.0B in reported holdings, 59 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}